E. William St. Clair
Impact in
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Immunology top 0.2%
- T-cell and B-cell Immunology
Papers in
- Rheumatology 85
- Rheumatoid Arthritis Research and Therapies 52
- Systemic Lupus Erythematosus Research 30
-
- Vasculitis and related conditions 64
- Co-authors
- Ravinder Nath Maini (8 shared papers)Paul Emery (6 shared papers)Peter E. Lipsky (5 shared papers)Daniel E. Fürst (4 shared papers)Michael H. Weisman (4 shared papers)Joachim R. Kalden (4 shared papers)Désirée van der Heijde (7 shared papers)Ferdinand C. Breedveld (2 shared papers)
- Journals
- Arthritis & Rheumatology (19 papers)Arthritis Care & Research (16 papers)Annals of the Rheumatic Diseases (10 papers)Lara D. Veeken (7 papers)The Journal of Immunology (4 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
E. William St. Clair
204 papers receiving 26.1k citations
E. William St. Clair's Hit Papers
Peers
Comparison fields: 5 of 155
- Rheumatology 13.4k
- Immunology 5.8k
- Hematology 2.9k
- Genetics 2.6k
- Pulmonary and Respiratory Medicine 6.2k
Countries citing papers authored by E. William St. Clair
This map shows the geographic impact of E. William St. Clair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. William St. Clair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. William St. Clair more than expected).
Fields of papers citing papers by E. William St. Clair
This network shows the impact of papers produced by E. William St. Clair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. William St. Clair. The network helps show where E. William St. Clair may publish in the future.
Co-authors
The 25 scholars most cited alongside E. William St. Clair, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 206 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis Hit paper breakdown → | 2000 | 2620 |
| 2 | 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Hit paper breakdown → | 2015 | 2364 |
| 3 | Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis Hit paper breakdown → | 2010 | 2066 |
| 4 | Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial Hit paper breakdown → | 1999 | 2039 |
| 5 | Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial Hit paper breakdown → | 2004 | 1009 |
| 6 | 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Hit paper breakdown → | 2021 | 981 |
| 7 | 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Hit paper breakdown → | 2015 | 958 |
| 8 | Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells Hit paper breakdown → | 2010 | 931 |
| 9 | Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies Hit paper breakdown → | 2005 | 645 |
| 10 | 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis Hit paper breakdown → | 2021 | 624 |
| 11 | Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis Hit paper breakdown → | 2013 | 580 |
| 12 | 2004 | 453 | |
| 13 | Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma Hit paper breakdown → | 2018 | 438 |
| 14 | 2001 | 400 | |
| 15 | 2006 | 379 | |
| 16 | 2002 | 367 | |
| 17 | A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial Hit paper breakdown → | 2012 | 333 |
| 18 | 2008 | 287 | |
| 19 | 1997 | 274 | |
| 20 | 2005 | 243 |
About E. William St. Clair
E. William St. Clair is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Immunology, Genetics and Immunology and Allergy, having authored 206 papers that have together received 27.5k indexed citations. Recurring topics across this work include Vasculitis and related conditions (64 papers), Rheumatoid Arthritis Research and Therapies (52 papers), Systemic Lupus Erythematosus Research (30 papers), T-cell and B-cell Immunology (22 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Immune Cell Function and Interaction (11 papers), Cell Adhesion Molecules Research (10 papers) and Salivary Gland Disorders and Functions (10 papers). The work is most often cited by research in Rheumatology (13.4k citations), Immunology (5.8k citations), Hematology (2.9k citations), Genetics (2.6k citations) and Pulmonary and Respiratory Medicine (6.2k citations). E. William St. Clair has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Ravinder Nath Maini, Paul Emery, Peter E. Lipsky, Daniel E. Fürst, Michael H. Weisman, Joachim R. Kalden, Désirée van der Heijde, Ferdinand C. Breedveld, Marc Feldmann and Gregory R. Harriman. Their work appears in journals such as Arthritis & Rheumatology, Arthritis Care & Research, Annals of the Rheumatic Diseases, Lara D. Veeken and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.